期刊文献+

RNA干扰下调CD98hc表达对胶质瘤细胞U251增殖、转移的影响 被引量:2

Effect of RNA interference down-regulation of CD98hc on proliferation,migration of U251 cells
下载PDF
导出
摘要 目的观察下调CD98hc对胶质瘤U251细胞体外增殖、迁移及侵袭的影响。方法应用si RNA技术干涉U251胶质瘤细胞CD98hc的表达,筛选并获得CD98hc低表达的U251细胞株(U251KD)及阴性对照细胞(U251NC)。流式细胞技术及Western blot鉴定CD98hc的表达下调情况。应用CCK-8细胞增殖实验检测两组细胞增殖;细胞划痕实验及Transwell小室分别检测两组细胞的迁移及侵袭能力;Western blot检测MMP-2、MMP-9的表达。结果与阴性对照U251NC组相比,U251KD细胞中CD98hc水平明显下调(P<0.01),U251KD细胞的增殖和迁移、侵袭能力均显著受抑(P<0.05),MMP-2、MMP-9的表达也明显降低(P<0.01)。结论下调CD98hc的表达能够明显抑制胶质瘤U251细胞的体外增殖、迁移及侵袭,其机制可能与MMP-2、MMP-9的下调相关。CD98hc分子可作为胶质瘤治疗的一个潜在靶点。 Objective To observe the effect of down-regulation of CD98 hc on proliferation, migration and invasion of U251 cells. Methods si RNA technology was used to interference CD98 hc in U251 cells. CD98 hc low expression U251cells(U251KD) and the negative control cells(U251NC) were obtained. FCM and Western blot were used to verify the down-regulation of CD98 hc. CCK-8 assay was used to test the cell proliferation of both U251 KD and U251 NC cells.Wound scratch assay and Transwell assay were conducted to determine the migration and invasion potency of U251 KD and U251 NC cells. Western blot was used to detect the expression of MMP-2 and MMP-9. Results Compared to that of U251 NC cells, CD98 hc was down-regulated significantly in U251 KD cells(P〈0.01). The cell proliferation, migration and invasion potency were significantly inhibited in U251 KD cells(P〈0.05); suppressing CD98 hc expression also down-regulated the expression of MMP-2 and MMP-9(P〈0.01). Conclusion Knocking down of CD98 hc inhibits the proliferation, migration and invasion of U251 cells in vitro, and the mechanism may be associated with the down-regulation of MMP-2 and MMP-9. CD98 hc can act as a potential target in glioma therapy.
出处 《中国医药导报》 CAS 2016年第17期16-19,24,共5页 China Medical Herald
基金 西安医学院博士科研启动基金项目(2015DOC08) 西安医学院分子免疫学重点学科建设经费
关键词 CD98分子 胶质瘤 细胞增殖 细胞侵袭 CD98 Glioma Cell proliferation Cell invasion
  • 相关文献

参考文献20

  • 1徐利民,陆永建,柳浩然.EMMPRIN基因表达对胶质瘤U251细胞增殖、凋亡的影响[J].武警医学,2012,23(3):223-226. 被引量:3
  • 2甄海宁,河井信行,冈田真树,大久保修一,田宫隆,章翔,刘卫平,霍军丽,费舟.4F2hc表达与人脑胶质瘤病理级别增殖和血管形成的关系[J].中国肿瘤临床,2012,29(16):1161-1164. 被引量:2
  • 3Morgan LU The epidemiology of glioma in aduhs:a "state of the science" review [J]. Neuro Oncol,2015,17(4) :623-624.
  • 4Cloughesy TF, Cavenee WK, Mischel PS. Glioblastoma : from molecular pathology to targeted treatment [J]. Annu Rev Pathol, 2014,9( 1 ): 1-25.
  • 5Wen PY,Reardon DA. Neuro-oneology in 2015:Progress in glioma diagnosis, classification and treatment [J]. Nat Rev Neurol, 2016,12 (2) : 69-70.
  • 6Krishnatry R,Zhukova N, Guerreim SA, et al. Clinical and treatment factors determining long-term outcomes for adult survivors of ehildhood low-grade glioma:A popula- tion-based study [J]. Cancer,2016,122(8) : 1261-1269.
  • 7Rosell A,Meury M,Alvarez-Marimon E,et al. Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc [J]. Proc Natl Aead Sci U S A, 2014,111 (8):2966- 2971.
  • 8Theodosakis N, Mieevie G, Sharma R, et al. Integrative discovery of CD98 as a Melanoma Biomarker [J]. Pigment Cell Melanoma Res, 2016,29(3) : 385-387.
  • 9Haining Z,Kawai N,Miyake K,et al. Relation of LAT1/ 4F2hc expression with pathological grade,proliferation andangiogenesis in human gliomas [J]. BMC Clin Pathol, 2012,12(1) :4.
  • 10Haynes BF. Human T lymphocyte antigens as defined by rnonoclonal antibodies [J]. Immunol Rev, 1981,57(1) : 127- 161.

二级参考文献10

  • 1Riethdorf S,Reimers N,Assmann V,et al.High incidenceof EMMRPIN expression in human tumors[J].Int J canc-er,2006,119(8):1800-1810.
  • 2Sameshima T,Nabeshima K,Toole BP,et al.Expression ofemmprin(CD147),a cell surface inducer of matrix metal-loproteinasese,in normal human brain andglomas[J].IntJ Cancet,2000,88(1):21-27
  • 3Zucker S,Hymowitz M,Rollo EE,et al.Tumorigenico-tential of extracellular matrix metalloproteinase inducer[J].Am J Pathol,2001,158(6):1921-1928.
  • 4Han ZD,He HC,Bi XC,et al.Expression and ClinicalSignificance of CD147 in Genitourinary Carcinomas[J].JSurg Res,2010,160(2):260-267.
  • 5Tang Y,Kesavan P,Nakada MT,et al.Tumor-stroma in-teraction:positive feedback regulation of extracellular ma-trix metalloproteinase inducer(EMMPRIN)expressionand matrix metalloproteinase-dependent generation ofsoluble EMMPRIN[J].Mol Cancer Res,2004,2(2):73-80.
  • 6Baba M,Inoue M,Itoh K,et al.Blocking CD147 in-duces cell death in cancer cells through impairment ofglycolytic energy metabolism[J].Biochem Biophys ResCommun,2008,374(1):111-116.
  • 7Xiang Chen,Jing Lin,Takuro Kanekura,et al.A SmallInfering CD147-Targeting RNA Inhibited the Prolifera-tion,Invasiveness,and Metastatic Activity of MalignantMelanoma[J].Cancer Res,2006,66(23):11323-11330.
  • 8Marieb EA,Zoltan-Jones A,Li R,et al.IncreasedEMMPRIN(CD147)expression during oral carcinogene-sis[J].Cancer Res,2004,64(4):1229-1232
  • 9Kanai Y,Endou H. Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity[J]. J Toxicol Sci,2003,28(1): 1-17.
  • 10Zhen HN,Zhang X,Hu PZ,et al. Survivin expression and its relation with proliferation,apoptosis,and angiogenesis in brain gliomas[J]. Cancer,2005,104(12): 2775-2783.

共引文献3

同被引文献3

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部